Retroviral Protease (RVP) DDI2 is a Viable Alternative for Full-Length (FL) DDI2

Authors
Publication date
9 December 2022
Publisher
Digital Scholarship@UNLV

Abstract

Proteasome inhibitors are drugs used to treat multiple myeloma. Currently, three are approved by the FDA.https://digitalscholarship.unlv.edu/durep_lightning/1020/thumbnail.jp

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Nevada, Las Vegas Repository

    redirect
    oaioai:digitalscholarship.unlv.ed...
    Last time updated on 09/03/2023